Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Status:
Completed
Trial end date:
2017-07-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects, good and/or bad, of standard of care
therapy (docetaxel or paclitaxel) with or without the addition of 1-Methyl-D-tryptophan
(referred to as indoximod) an experimental drug to find out which treatment is better.